Analysis of the secreted “cytokine signature” in the extracellular milieu of luminal-like ER+ breast cancer cells exhibiting an HRG-driven endocrine-resistant phenotype revealed the differential upregulation of three well-known regulators of ERα activity, namely, uPAR, amphiregulin, and IL-8. This evidence concerns the gene CXCL8 and breast cancer.